Meduri G, Bachelot A, Duflos C, et al. FOXL2 mutations lead to different ovarian phenotypes in BPES patients: Case report. Hum Reprod. 2010;25(1):235-243. doi:10.1093/humrep/dep355
Meng T, Zhang W, Zhang R, et al. Ovarian reserve and ART outcomes in blepharophimosis-ptosis-epicanthus inversus syndrome patients with FOXL2 mutations. Front Endocrinol (Lausanne). 2022;13. doi:10.3389/fendo.2022.829153
Tyers AG. The blepharophimosis-ptosis-epicanthus inversus syndrome (BPES). Orbit. 2011;30(5):199-201. doi:10.3109/01676830.2010.547266


